1. Home
  2. APT vs GANX Comparison

APT vs GANX Comparison

Compare APT & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APT
  • GANX
  • Stock Information
  • Founded
  • APT 1983
  • GANX 2017
  • Country
  • APT Canada
  • GANX United States
  • Employees
  • APT N/A
  • GANX N/A
  • Industry
  • APT
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • APT
  • GANX Health Care
  • Exchange
  • APT Nasdaq
  • GANX Nasdaq
  • Market Cap
  • APT 61.6M
  • GANX 53.8M
  • IPO Year
  • APT 1995
  • GANX 2021
  • Fundamental
  • Price
  • APT $4.56
  • GANX $1.92
  • Analyst Decision
  • APT
  • GANX Strong Buy
  • Analyst Count
  • APT 0
  • GANX 5
  • Target Price
  • APT N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • APT 42.1K
  • GANX 215.9K
  • Earning Date
  • APT 05-08-2025
  • GANX 05-14-2025
  • Dividend Yield
  • APT N/A
  • GANX N/A
  • EPS Growth
  • APT 2.28
  • GANX N/A
  • EPS
  • APT 0.36
  • GANX N/A
  • Revenue
  • APT $58,180,000.00
  • GANX N/A
  • Revenue This Year
  • APT N/A
  • GANX N/A
  • Revenue Next Year
  • APT N/A
  • GANX N/A
  • P/E Ratio
  • APT $12.84
  • GANX N/A
  • Revenue Growth
  • APT N/A
  • GANX N/A
  • 52 Week Low
  • APT $4.06
  • GANX $0.89
  • 52 Week High
  • APT $6.44
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • APT 47.84
  • GANX 51.55
  • Support Level
  • APT $4.25
  • GANX $1.76
  • Resistance Level
  • APT $5.16
  • GANX $2.07
  • Average True Range (ATR)
  • APT 0.23
  • GANX 0.13
  • MACD
  • APT 0.01
  • GANX 0.01
  • Stochastic Oscillator
  • APT 34.07
  • GANX 52.94

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: